BR0015542A - Cloning and characterization of the cap gene promoter - Google Patents

Cloning and characterization of the cap gene promoter

Info

Publication number
BR0015542A
BR0015542A BR0015542-0A BR0015542A BR0015542A BR 0015542 A BR0015542 A BR 0015542A BR 0015542 A BR0015542 A BR 0015542A BR 0015542 A BR0015542 A BR 0015542A
Authority
BR
Brazil
Prior art keywords
cloning
characterization
cap
promoter
new polynucleotides
Prior art date
Application number
BR0015542-0A
Other languages
Portuguese (pt)
Inventor
Christian A Baumann
Vered Ribon
Alan Robert Saltiel
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0015542A publication Critical patent/BR0015542A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"CLONAGEM E CARACTERIZAçãO DO PROMOTOR DO GENE CAP". A presente invenção refere-se a novos polinucleotídeos que contêm elementos de resposta proliferadora de peroxisoma (PPREs). A invenção também descreve vetores e células hospedeiras que compreendem os novos polinucleotídeos. A invenção descreve também processos para usar os novos polinucleotídeos, aplicações de terapia gênica, diagnósticos para síndromes que envolvem resistência à insulina, desenvolvimento de estratégias de seleção de propriedade particular para inibidores de ligandos ou proteínas que se ligam, se associam ou interagem com o promotor CAP."CLONING AND CHARACTERIZATION OF THE GENE CAP PROMOTER". The present invention relates to new polynucleotides that contain peroxisome proliferating response elements (PPREs). The invention also describes vectors and host cells that comprise the new polynucleotides. The invention also describes processes for using the new polynucleotides, gene therapy applications, diagnoses for syndromes that involve insulin resistance, development of particular property selection strategies for inhibitors of ligands or proteins that bind, associate with or interact with the promoter CAP.

BR0015542-0A 1999-11-12 2000-10-17 Cloning and characterization of the cap gene promoter BR0015542A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16522199P 1999-11-12 1999-11-12
PCT/US2000/028686 WO2001036619A2 (en) 1999-11-12 2000-10-17 Cloning and characterization of the cap gene promoter

Publications (1)

Publication Number Publication Date
BR0015542A true BR0015542A (en) 2002-12-31

Family

ID=22597977

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015542-0A BR0015542A (en) 1999-11-12 2000-10-17 Cloning and characterization of the cap gene promoter

Country Status (7)

Country Link
EP (1) EP1232261A2 (en)
JP (1) JP2003517302A (en)
AU (1) AU1209601A (en)
BR (1) BR0015542A (en)
CA (1) CA2385090A1 (en)
TR (1) TR200201302T2 (en)
WO (1) WO2001036619A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1652922A4 (en) * 2003-08-08 2007-09-19 Astellas Pharma Inc Novel protein usable in screening drug for improving type 2 diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753431A (en) * 1993-10-13 1998-05-19 Northeastern Ohio University Cholesterol 7 α-hydroxdylase gene regulatory elements and transcription factors

Also Published As

Publication number Publication date
WO2001036619A3 (en) 2002-01-17
EP1232261A2 (en) 2002-08-21
WO2001036619A2 (en) 2001-05-25
CA2385090A1 (en) 2001-05-25
AU1209601A (en) 2001-05-30
TR200201302T2 (en) 2002-08-21
JP2003517302A (en) 2003-05-27

Similar Documents

Publication Publication Date Title
Tu et al. Tissue-specific expression of the rat glutathione S-transferases.
Zomerdijk et al. Assembly of transcriptionally active RNA polymerase I initiation factor SL1 from recombinant subunits
Knight et al. Identification in collagen type I of an integrin α2β1-binding site containing an essential GER sequence
Hallier et al. The Transcription Factor Spi-1/PU. 1 Binds RNA and Interferes with the RNA-binding Protein p54nrb (∗)
Germann et al. Characterization of two allelic forms of Neurospora crassa laccase. Amino-and carboxyl-terminal processing of a precursor.
Veals et al. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins
ATE252151T1 (en) VERTEBRATE APOPTOSIS GENES, COMPOSITIONS AND USES
BR9908226A (en) Improvement of the circulating half-life of fusion proteins based on antibody
DK1005488T3 (en) Receptor that binds TRAIL
BR0316435A (en) Genetic products differentially expressed in and use of tumors
FI972390A0 (en) A cytokine called Lerk-7
WO2002010195A3 (en) Modified peptides with increased potency
DE60235039D1 (en) EGVII ENDOGLUCANASE AND NUCLEIC ACIDS CODING THEREOF
PT737207E (en) HUMAN PLASMA INHIBITORS DERIVED FROM KUNITZ DOMAINS
YU8997A (en) Purified protein having serinic proteaze inhibiting activity and pharmaceutical preparation containing them
NO960652L (en) Cytokines that bind the cell surface receptor to witch
ATE418563T1 (en) NIK PROTEINS, NUCLEIC ACID AND METHODS
Baichoo et al. Mapping conformational changes in a protein: application of a protein footprinting technique to cAMP-induced conformational changes in cAMP receptor protein
BR0015542A (en) Cloning and characterization of the cap gene promoter
CA2281955A1 (en) Ikb kinase, subunits thereof, and methods of using same
ATE196775T1 (en) PURIFIED MAMMAL FLT3 LIGANDS, AGONISTS AND ANTAGONISTS THEREOF
WO1994028132A3 (en) Opioid receptors: compositions and methods
Heyd et al. Reinvestigation of the proteolytic activity of neocarzinostatin
Weitman et al. A monoclonal antibody that distinguishes latent and active forms of the proteasome (multicatalytic proteinase complex).
WO2000075324A3 (en) Recombinant prion-like genes and proteins and materials and methods comprising same

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]